biote Corp. (NASDAQ:BTMD) Holdings Boosted by Trexquant Investment LP

Trexquant Investment LP increased its position in biote Corp. (NASDAQ:BTMD - Free Report) by 423.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 101,757 shares of the company's stock after buying an additional 82,303 shares during the period. Trexquant Investment LP owned about 0.19% of biote worth $629,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Commonwealth Equity Services LLC acquired a new position in biote in the fourth quarter valued at $68,000. Intech Investment Management LLC acquired a new stake in shares of biote in the fourth quarter worth approximately $71,000. SG Americas Securities LLC purchased a new stake in biote in the fourth quarter valued at approximately $76,000. Thompson Davis & CO. Inc. acquired a new position in biote during the fourth quarter worth approximately $77,000. Finally, Jane Street Group LLC raised its stake in biote by 24.7% during the third quarter. Jane Street Group LLC now owns 16,873 shares of the company's stock worth $94,000 after purchasing an additional 3,342 shares during the period. Hedge funds and other institutional investors own 21.68% of the company's stock.

Wall Street Analyst Weigh In

Separately, Craig Hallum cut their target price on biote from $12.00 to $8.00 and set a "buy" rating on the stock in a research report on Thursday, March 13th.

Remove Ads

biote Trading Down 2.3 %

BTMD traded down $0.08 during trading on Tuesday, hitting $3.45. 140,200 shares of the company's stock were exchanged, compared to its average volume of 185,558. The firm has a market cap of $188.75 million, a P/E ratio of 13.27 and a beta of 1.17. The stock has a 50 day moving average price of $4.04 and a 200 day moving average price of $5.17. biote Corp. has a 1 year low of $3.04 and a 1 year high of $8.44.

Insider Activity at biote

In other news, major shareholder Guines Llc acquired 750,000 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was bought at an average cost of $3.22 per share, with a total value of $2,415,000.00. Following the transaction, the insider now directly owns 3,820,938 shares in the company, valued at approximately $12,303,420.36. This represents a 24.42 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stephen Mark Cone purchased 38,104 shares of biote stock in a transaction that occurred on Monday, March 17th. The stock was acquired at an average cost of $3.88 per share, with a total value of $147,843.52. Following the acquisition, the director now directly owns 160,829 shares of the company's stock, valued at $624,016.52. The trade was a 31.05 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 958,435 shares of company stock worth $3,118,936. 13.90% of the stock is currently owned by company insiders.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.